Search research articles
Contact Us
Filters
Showing results (251-260 of 278) with videos related to
Page
of 28
Sort By:
Cancer Discovery
|
February 13, 2015
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations
Leanne G Ahronian, Erin M Sennott, Eliezer M Van Allen, et al.
Cancer Cell
|
January 9, 2026
Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC program
Salvador Alonso, Kanwal Raghav, Van K Morris, et al.
Cancer Research
|
June 18, 2016
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
Daniele Oddo, Erin M Sennott, Ludovic Barault, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2021
Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer
Giulia Siravegna, Connor J O'Boyle, Shohreh Varmeh, et al.
Cancer Discovery
|
November 2, 2023
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations
Andreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin, et al.
Cancer Discovery
|
December 31, 2016
Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma
Lipika Goyal, Supriya K Saha, Leah Y Liu, et al.
Cancer Discovery
|
January 22, 2014
Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit
Zehua Zhu, Amir R Aref, Travis J Cohoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2020
Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Aparna R Parikh, Amikasra Mojtahed, Jaime L Schneider, et al.
Nature Medicine
|
January 13, 2026
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis
Brendan M Crowley, Helena I Boshoff, Aidan Boving, et al.
Cancer Discovery
|
January 8, 2026
Acquired on-target alterations drive clinical resistance to p53-Y220C reactivators
Ferran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 278) with videos related to
Sort By:
Page
of 28
Cancer Discovery
|
February 13, 2015
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations
Leanne G Ahronian, Erin M Sennott, Eliezer M Van Allen, et al.
Cancer Cell
|
January 9, 2026
Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC program
Salvador Alonso, Kanwal Raghav, Van K Morris, et al.
Cancer Research
|
June 18, 2016
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
Daniele Oddo, Erin M Sennott, Ludovic Barault, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2021
Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer
Giulia Siravegna, Connor J O'Boyle, Shohreh Varmeh, et al.
Cancer Discovery
|
November 2, 2023
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations
Andreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin, et al.
Cancer Discovery
|
December 31, 2016
Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma
Lipika Goyal, Supriya K Saha, Leah Y Liu, et al.
Cancer Discovery
|
January 22, 2014
Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit
Zehua Zhu, Amir R Aref, Travis J Cohoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2020
Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Aparna R Parikh, Amikasra Mojtahed, Jaime L Schneider, et al.
Nature Medicine
|
January 13, 2026
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis
Brendan M Crowley, Helena I Boshoff, Aidan Boving, et al.
Cancer Discovery
|
January 8, 2026
Acquired on-target alterations drive clinical resistance to p53-Y220C reactivators
Ferran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel, et al.
Page
of 28